NCT05470881View on ClinicalTrials.gov

Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 20, 2022

Primary Completion Date

December 26, 2022

Study Completion Date

December 26, 2022

Conditions
Myopia
Interventions
DRUG

Atropine Sulfate

Administration of one drop QD on both eyes for 14 days.

Trial Locations (1)

44610

IIMET Investigación e Innovación en Medicina Traslacional, Guadalajara

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY